U.K. to buy an additional 60 million doses of Moderna's COVID-19 vaccine

Moderna Inc. /zigman2/quotes/205619834/composite MRNA +0.98% said Thursday that the U.K. purchased an additional 60 million doses of its COVID-19 vaccine, to be delivered in 2022 and 2023. As part of the agreement, the doses can include boosters, and the U.K. can increase or decrease the number of doses it's buying by 20%. Moderna's stock is up 197.3% so far this year, while the broader S&P 500 /zigman2/quotes/210599714/realtime SPX +0.56% has gained 21.6%.

/zigman2/quotes/205619834/composite

Add to watchlist MRNA

Moderna Inc.

US : U.S.: Nasdaq

$ 150.88

+1.46 +0.98%

Volume: 1.99M

March 24, 2023 4:00p

P/E Ratio

7.55

Dividend Yield

N/A

Market Cap

$58.29 billion

Rev. per Employee

$4.90M

/zigman2/quotes/210599714/realtime

Add to watchlist SPX

S&P 500 Index

US : S&P US

3,970.99

+22.27 +0.56%

Volume: 0.00

March 24, 2023 5:02p